Transaction DateRecipientSharesTypePriceValue
24th January 2020James E Dentzer3,094Open or private sale$1.64$5,076.33
23rd January 2020James E Dentzer3,658Open or private sale$1.69$6,181.65
22nd February 2019Marc Rubin859Exercise of derivative$2.39$2,053.01
22nd February 2019Marc Rubin859Open or private sale$6.02$5,174.96
21st February 2019Marc Rubin43,326Open or private sale$6.02$261,026.15
21st February 2019Marc Rubin7,000Open or private sale$6.00$42,000.00
21st February 2019Marc Rubin43,326Exercise of derivative$2.39$103,549.14
24th January 2019James E Dentzer3,094Open or private sale$1.16$3,576.97
23rd January 2019Lori Anne Kunkel14,800Open or private sale$1.05$15,581.44
23rd January 2019James E Dentzer2,397Open or private sale$1.09$2,612.73
Curis logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948,CA-170, and CA-327. The company was founded in 2000 and is headquartered in Lexington, MA.

Ticker: CRIS
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1108205
Employees: 28
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $24 M (0%)
Marketable Securities, Current: $153 Th (0%)
Assets, Current: $27 M (9%)
Property, Plant and Equipment, Net: $737 Th (378%)
Other Assets, Noncurrent: $2 Th (-33%)
Assets: $45 M (28%)
Accounts Payable, Current: $5 M (11%)
Accrued Liabilities, Current: $2 M (0%)
Liabilities, Current: $9 M (42%)
Liabilities: $75 M (9%)
Common Stock, Value, Issued: $506 Th (52%)
Common Stock, Shares, Issued: $51 M (52%)
Additional Paid in Capital, Common Stock: $1 B (2%)
Retained Earnings (Accumulated Deficit): $1 B (3%)
Stockholders' Equity (Parent): $30 M (0%)
Liabilities and Equity: $45 M (28%)
Revenue: $2 M (-53%)
General and Administrative Expenses: $2 M (-60%)
Operating Income/Loss: $5 M (-60%)
Other Income, net: $1 M (-48%)